Alfasigma

Alfasigma

Alfasigma, formerly Pamlab, is a company that develops personalized pharmaceuticals and medicine

Alfasigma is based in Los Angeles, California, United States.

The company works with drugs such as Deplin L-methylfolate Ca, VSL#3 The Living Shield, Metanx L-methylfolate Ca/P-5-P/Me-Cbl, CerefolinNAC L-methylfolate Ca/Me-Cbl/NAC, Carnitine bulk ingredients, Brand Direct Health, PrOxeedPluss, and NeevoDHA.

Alfasigma acquired ZELNORM in March of 2019. Zelnorm is a prescription pharmaceutical treatment option for irritable bowel syndrome with constipation. The drug works by targeting the 5-HT4 receptor at multiple neurons, and smooth muscle cells in the gastrointestinal tract to induce contraction and relaxation. It also aims to decrease pain signaling.

The company acquired DELPIN which is a drug designed to help meet the nutritional needs of people with depression and is usable with antidepressants. It is formulated with L-methylfolate and can be used after initial antidepressant therapy.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Add the Missing Peace

Web

Alfasigma USA, Inc.

Web

Alfasigma USA, Inc.

Web

Zelnorm - Alfsasigma USA, Inc.

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Pamlab (Alfasigma)

Los Angeles, California, United States

Personalized Pharmaceuticals

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.